As a homologue of BAFF, elevated levels of a proliferation-inducing ligand (APRIL) have also been reported in SSc patients and have been identified as a marker for pulmonary fibrosis, whilst high BAFF levels indicate severe skin sclerosis (109). This evidence concerns the gene TNFSF13B and pulmonary fibrosis.